Table 1.
Demographic characteristics of DHS samples, including HP duplication genotypes (data shown are mean ± SD, unless specified otherwise)
|
DHS Demographics | ||||
|---|---|---|---|---|
| |
|
HP Genotypes |
||
| Total | 1/1 | 1/2 | 2/2 | |
| Number |
1208 |
168 |
505 |
535 |
| Age (years) |
61.5 ± 9.35 |
62.5 ± 9.36 |
61.2 ± 9.34 |
61.5 ± 9.36 |
| Female (%) |
643 (53.2) |
87 (51.8) |
274 (54.3) |
282 (52.7) |
| BMI (kg/m2) |
31.8 ± 6.49 |
31.9 ± 6.27 |
32.1 ± 6.81 |
31.4 ± 6.23 |
| Affected (%) |
1013 (83.9) |
134 (79.8) |
431 (85.4) |
448 (83.7) |
| Diabetes duration (years) |
10.41 ± 7.1 |
10.95 ± 7.9 |
10.15 ± 7.24 |
10.49 ± 6.86 |
| Metabolic Syndrome (%) |
1029 (85.2) |
140 (83.3) |
434 (85.9) |
455 (85.1) |
| Glucose (mg/dL) |
139.4 ± 55.5 |
139.7 ± 58.8 |
142.3 ± 56.7 |
136.7 ± 53.1 |
| HbA1c (%) |
7.29 ± 1.7 |
7.13 ± 1.57 |
7.31 ± 1.78 |
7.32 ± 1.78 |
| C-reactive protein (mg/dl) |
0.59 ± 0.97 |
0.54 ± 0.81 |
0.60 ± 1.05 |
0.59 ± 0.94 |
| Hypertension (%) |
1025 (84.85) |
141 (83.93) |
422 (83.56) |
462 (86.36) |
| Smoking (%) |
708 (58.85) |
96 (57.49) |
285 (56.55) |
327 (61.47) |
| Lipid medication (%) |
540 (44.7) |
76 (45.24) |
221 (43.76) |
243 (45.42) |
| Anti-hypertensive medication (%) |
747 (61.84) |
101 (60.12) |
324 (64.16) |
322 (60.19) |
| CAC |
1662.5 ± 3160.7 |
1679.1 ± 2449.8 |
1607.2 ± 3001.5 |
1708.5 ± 3492.3 |
| CarCP |
312.9 ± 672.1 |
276.2 ± 522.5 |
292.8 ± 610.8 |
343.3 ± 762.4 |
| AACP |
10949.3 ± 15748.8 |
12628.86 ± 16231.1 |
9781.9 ± 14236.0 |
11458.1 ± 16775.3 |
| IMT (mm) |
0.676 ± 0.134 |
0.677 ± 0.136 |
0.665 ± 0.129 |
0.686 ± 0.139 |
| Cholesterol (mg/dL) |
186.8 ± 42.4 |
187.5 ± 46.2 |
187.7 ± 43.4 |
185.8 ± 40.3 |
| LDL (mg/dL) |
105.1 ± 32.7 |
104.0 ± 35.3 |
103.3 ± 30.8 |
107.1 ± 33.5 |
| HDL (mg/dL) |
43.1 ± 12.5 |
43.5 ± 14.4 |
43.3 ± 12.7 |
42.7 ± 11.6 |
| Triglycerides (mg/dL) |
201.4 ± 132.1 |
212.8 ± 162.3 |
208.8 ± 133.7 |
190.9 ± 119.2 |
| History of CVD (%) |
471 (38.99) |
72 (42.86) |
191 (37.82) |
208 (38.88) |
| Non-CVD Mortality (%) |
122 (10.10) |
19 (11.31) |
49 (9.70) |
54 (10.09) |
| CVD Mortality (%) | 100 (8.28) | 11 (6.55) | 34 (6.73) | 55 (10.28) |